tilmicosin and Leptospirosis

tilmicosin has been researched along with Leptospirosis* in 2 studies

Trials

1 trial(s) available for tilmicosin and Leptospirosis

ArticleYear
Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo.
    Journal of the American Veterinary Medical Association, 2001, Sep-01, Volume: 219, Issue:5

    To evaluate antibiotics for treatment of cattle with leptospirosis caused by Leptospira borgpetersenii serovar hardjo.. Randomized controlled trial.. 42 healthy mixed-breed cattle.. Cattle were inoculated via conjunctival instillation with L. borgpetersenii serovar hardjo. After infection and urinary shedding of L. borgpetersenii were confirmed, cattle were treated with various antibiotics. To determine effectiveness of antibiotic treatment, urinary shedding of L. borgpetersenii was monitored for 4 to 6 weeks after administration of antibiotics, using darkfield microscopic examination, microbial culture, immunofluorescence testing, and a polymerase chain reaction assay.. All inoculated cattle developed leptospirosis and shed leptospires in their urine. The following antibiotic treatments resulted in elimination of urinary shedding of leptospires: a single injection of oxytetracycline (20 mg/kg 19 mg/lb] of body weight, IM), tilmicosin (10 mg/kg [4.5 mg/lb], SC), or a combination product that contained dihydrostreptomycin-penicillin G (25 mg/kg [11.4 mg/lb], IM) or multiple injections of ceftiofur sodium (2.2 or 5 mg/kg [1 or 2.3 mg/lb], IM, once daily for 5 days, or 20 mg/kg, IM, once daily for 3 days).. Successful resolution of leptospirosis in cattle by administration of dihydrostreptomycin-penicillin G confirms results obtained by other investigators. Three other antibiotics (oxytetracycline, tilmicosin, and ceftiofur) also were effective for resolving leptospirosis and may be useful substitutes for dihydrostreptomycin, an antibiotic that is no longer available for use in food-producing animals in the United States. Cost, safety, and withdrawal times of these various treatment options need to be considered.

    Topics: Animals; Anti-Bacterial Agents; Bacteriuria; Cattle; Cattle Diseases; Cephalosporins; Dihydrostreptomycin Sulfate; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Leptospira; Leptospirosis; Macrolides; Male; Oxytetracycline; Penicillin G; Polymerase Chain Reaction; Treatment Outcome; Tylosin

2001

Other Studies

1 other study(ies) available for tilmicosin and Leptospirosis

ArticleYear
In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin.
    Journal of veterinary science, 2006, Volume: 7, Issue:4

    Antimicrobial susceptibility testing was conducted with 6 different spirochetal strains (4 strains of Leptospira spp. and 2 strains of Borrelia burgdorferi) against 3 antimicrobial agents, commonly used in equine and bovine practice. The ranges of MIC and MBC of amoxicillin against Leptospira spp. were 0.05 - 6.25 microgram/ml and 6.25 - 25.0 microgram/ml, respectively. And the ranges of minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of amoxicillin against B. burgdorferi were 0.05 - 0.39 microgram/ml and 0.20 - 0.78 microgram/ml, respectively. The ranges of MIC and MBC of enrofloxacin against Leptospira spp. were 0.05 - 0.39 microgram/ml and 0.05 - 0.39 microgram/ml, respectively. Two strains of B. burgdorferi were resistant to enrofloxacin at the highest concentration tested for MBC (>or=100 microgram/ml). Therefore, the potential role of tilmicosin in the treatment of leptospirosis and borreliosis should be further evaluated in animal models to understand whether the in vivo studies will confirm in vitro results. All spirochetal isolates were inhibited (MIC) and were killed (MBC) by tilmicosin at concentrations below the limit of testing (

    Topics: Amoxicillin; Anti-Bacterial Agents; Borrelia burgdorferi; Enrofloxacin; Fluoroquinolones; Leptospira; Leptospirosis; Lyme Disease; Macrolides; Microbial Sensitivity Tests; Reproducibility of Results; Tylosin

2006